BMRN vs TOVX · P/E 40, rev $1.76B vs rev $300.0K
Biomarin Pharmaceutical Inc (BMRN) versus Theriva Biologics Inc. (TOVX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. TOVX currently screens at market cap $12.4M.
Not investment advice. Open the BMRN and TOVX stock pages for the full models.
Not investment advice.